Anatoly Dritschilo
Chief Executive Officer at SHUTTLE PHARMACEUTICALS HOLDINGS, INC.
Net worth: 2 M $ as of 29/04/2024
Profile
Anatoly Dritschilo is the founder of Shuttle Pharmaceuticals, Inc. and Shuttle Pharmaceuticals Holdings, Inc., both founded in 2012.
He currently holds the title of Chairman & Chief Executive Officer at both companies.
Dr. Dritschilo also held the position of Founding Director at NeoPharm, Inc. In addition, he served as the Medical Director at Georgetown University Hospital from 1994 to 1997, Director at Georgetown Lombardi Comprehensive Cancer Center from 2005 to 2007, and Chief-Radiation Oncology at Georgetown University Hospital from 2005 to 2016.
Dr. Dritschilo completed his undergraduate studies at the University of Pennsylvania and obtained a doctorate degree from New Jersey Medical School.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 20/03/2024 | 4,289,607 ( 25.54% ) | 2 M $ | 29/04/2024 |
Anatoly Dritschilo active positions
| Companies | Position | Start |
|---|---|---|
| SHUTTLE PHARMACEUTICALS HOLDINGS, INC. | Chief Executive Officer | 17/12/2012 |
Shuttle Pharmaceuticals, Inc.
 Shuttle Pharmaceuticals, Inc. BiotechnologyHealth Technology Shuttle Pharmaceuticals, Inc. operates as a pharmaceutical company which engages in the development and commercialization of drugs. It focuses on innovative drugs for sensitizing cancers to and protecting normal tissue from the effects of radiation therapy. The firm's products include novel HDAC inhibitor cancer drug candidates. The company was founded by Anatoly Dritschilo, Milton Brown, and Mira Jung in December 2012 and is headquartered in Rockville, MD. | Chief Executive Officer | 30/11/2012 |
Former positions of Anatoly Dritschilo
| Companies | Position | End |
|---|---|---|
Georgetown University Hospital
 Georgetown University Hospital Medical DistributorsDistribution Services Georgetown University Hospital provides healthcare services. Its services include cancer care, blood cancer, leukemia and myelodysplastic syndromes. The company is headquartered in Washington, DC. | Corporate Officer/Principal | 31/12/2015 |
Georgetown Lombardi Comprehensive Cancer Center
 Georgetown Lombardi Comprehensive Cancer Center Hospital/Nursing ManagementHealth Services Georgetown Lombardi Comprehensive Cancer Center is a comprehensive cancer center designated by the National Cancer Institute (NCI) and is a part of Georgetown University Medical Center. It is located in Washington, D.C. and is supported in part by a National Cancer Institute Cancer Center Support Grant. It is the only comprehensive cancer center in the area and serves as the research engine for MedStar Health, Georgetown University’s clinical partner. Georgetown Lombardi seeks to improve the diagnosis, treatment, and prevention of cancer through innovative basic, translational, and clinical research, patient care, and community education and outreach. Georgetown Lombardi also offers a master’s degree program in cancer biology, prevention, and control in partnership with the University of the District of Columbia (UDC). | Director/Board Member | 31/12/2006 |
Georgetown University Hospital
Georgetown University Hospital Medical DistributorsDistribution Services Georgetown University Hospital provides healthcare services. Its services include cancer care, blood cancer, leukemia and myelodysplastic syndromes. The company is headquartered in Washington, DC. | Chief Tech/Sci/R&D Officer | 31/12/1996 |
NeoPharm, Inc.
 NeoPharm, Inc. BiotechnologyHealth Technology NeoPharm, Inc. engages in the research, development, and commercialization of drugs for the treatment of various cancers and other diseases. The company has built its drug development program around two proprietary technology platforms, a tumor-targeting toxin platform which includes development for a new indication of Pulmonary Fibrosis, and a novel NeoLipid liposomal drug delivery system. It has advanced five drug product candidates in various stages of clinical and pre clinical development for the treatment of cancer and one drug product candidate in pre-clinical development for treatment of interstitial pulmonary fibrosis and asthma. NeoPharm was founded in May 15, 1900and is headquartered in Lake Bluff, IL. | Corporate Officer/Principal | - |
Training of Anatoly Dritschilo
| University of Pennsylvania | Undergraduate Degree |
| New Jersey Medical School | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| SHUTTLE PHARMACEUTICALS HOLDINGS, INC. | Health Technology |
| Private companies | 4 |
|---|---|
NeoPharm, Inc.
NeoPharm, Inc. BiotechnologyHealth Technology NeoPharm, Inc. engages in the research, development, and commercialization of drugs for the treatment of various cancers and other diseases. The company has built its drug development program around two proprietary technology platforms, a tumor-targeting toxin platform which includes development for a new indication of Pulmonary Fibrosis, and a novel NeoLipid liposomal drug delivery system. It has advanced five drug product candidates in various stages of clinical and pre clinical development for the treatment of cancer and one drug product candidate in pre-clinical development for treatment of interstitial pulmonary fibrosis and asthma. NeoPharm was founded in May 15, 1900and is headquartered in Lake Bluff, IL. | Health Technology |
Georgetown University Hospital
Georgetown University Hospital Medical DistributorsDistribution Services Georgetown University Hospital provides healthcare services. Its services include cancer care, blood cancer, leukemia and myelodysplastic syndromes. The company is headquartered in Washington, DC. | Distribution Services |
Shuttle Pharmaceuticals, Inc.
Shuttle Pharmaceuticals, Inc. BiotechnologyHealth Technology Shuttle Pharmaceuticals, Inc. operates as a pharmaceutical company which engages in the development and commercialization of drugs. It focuses on innovative drugs for sensitizing cancers to and protecting normal tissue from the effects of radiation therapy. The firm's products include novel HDAC inhibitor cancer drug candidates. The company was founded by Anatoly Dritschilo, Milton Brown, and Mira Jung in December 2012 and is headquartered in Rockville, MD. | Health Technology |
Georgetown Lombardi Comprehensive Cancer Center
Georgetown Lombardi Comprehensive Cancer Center Hospital/Nursing ManagementHealth Services Georgetown Lombardi Comprehensive Cancer Center is a comprehensive cancer center designated by the National Cancer Institute (NCI) and is a part of Georgetown University Medical Center. It is located in Washington, D.C. and is supported in part by a National Cancer Institute Cancer Center Support Grant. It is the only comprehensive cancer center in the area and serves as the research engine for MedStar Health, Georgetown University’s clinical partner. Georgetown Lombardi seeks to improve the diagnosis, treatment, and prevention of cancer through innovative basic, translational, and clinical research, patient care, and community education and outreach. Georgetown Lombardi also offers a master’s degree program in cancer biology, prevention, and control in partnership with the University of the District of Columbia (UDC). | Health Services |
- Stock Market
- Insiders
- Anatoly Dritschilo